11:54 Debate: Targeted therapy for RAS/BRAF WT left sided colon cancers - Bevacizumab or EGFR antibodies HMP Education
17:17 Debate: Targeted therapy for RAS/BRAF WT left sided colon cancers - EGFR antibodies are mandatory HMP Education
9:06 Debate: Is there an optimal treatment for refractory colorectal cancer? - TAS-102 or regorafenib HMP Education
9:12 Debate: Is there an optimal treatment for refractory colorectal cancer? - Immunotherapy HMP Education
16:10 Debate: Is observation without surgery reasonable for rectal cancers achieving a clinical CR? - Yes HMP Education
8:59 Debate: Is observation without surgery reasonable for rectal cancers achieving a clinical CR? -No HMP Education
12:01 Debate: Is circulating tumor DNA ready to guide adjuvant therapy in colon cancer? - Yes HMP Education
21:11 Update: The role of aspirin therapy in GI cancer survivors and the general population HMP Education
15:52 Debate: Are novel targets such as HER2 ready for prime time in colorectal cancer? - No HMP Education
